The allergy treatment market was valued at US$ 21,160.92 million in 2020 and is projected to reach US$ 35,812.33 million by 2028; it is expected to grow at a CAGR of 6.9% from 2021 to 2028.
The allergies are hypersensitive responses from human immune system to the substance that are foreign to the body. Dust mite, animal dander, cockroach, pollens, mold, food substances, and metal and element particles are among the common allergens. While allergies can disturb the normal functioning of organs, severe allergies can be life threatening; for example, asthma leads to poor lung functioning. Although the most effective method of gaining protection against allergies is to avoid being exposed to the known allergens, medications such as steroids and antihistamines are available for treating them.
The allergy treatment market is segmented on the basis of allergy type, treatment, and geography. By geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report offers insights and in-depth analysis of the allergy treatment market, emphasizing on parameters such as market trends, technological advancements, and market dynamics along with the analysis of competitive landscape of world’s leading market players.
Download sample Report Copy @ https://www.theinsightpartners.com/sample/TIPRE00004584/
A few prominent players operating in the allergy treatment market are Johnson and Johnson Services, Inc.; Sanofi; AbbVie Inc. (Allergan plc); Pfizer Inc.; LETIPharma; ALK-Abelló A/S; Allergy Therapeutics; Stallergenes Greer; GlaxoSmithKline plc; and Dermapharm Holding.
Based on allergy type, the global allergy treatment market is segmented into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies. In 2020, the rhinitis segment held the largest share of the market; it is also expected to be a leading shareholder in the market by 2028. The market growth is mainly attributed to the growing prevalence of rhinitis worldwide, which is likely to continue in the coming years due to constant climatic and environmental changes, thereby boosting the demand for decongestants, antihistamines, and topical/oral steroids worldwide.
The increasing adoption of immunotherapy in allergy treatment and advancements in food allergy treatment options are driving the growth of the global allergy treatment market. However, the lack of awareness about allergies and their treatments is limiting the market growth.
The COVID-19 pandemic is estimated to have a positive impact on the allergy treatment market. Majority of the pharmaceutical companies across the world are engaged in the development of vaccines against this disease. Moreover, allergy and asthma exacerbations are frequently triggered by viral infections, including coronaviruses. Thus, telehealth can be central in delivering allergy/immunology services within a risk-stratified context of the SARS-CoV-2 pandemic which is anticipated to have a positive impact on the other segments of the market in the coming months. However, disruptions in the supply chain caused due to the halt in global operations are hindering the market growth.
Global Allergy Treatment Market By Geography
• North America
• Europe
- France
- Germany
- UK
- Italy
- Spain
- Rest of Europe
• Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
• Middle East and Africa (MEA)
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East and Africa
• South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Purchase Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00004584/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defence.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UMEMFKNN7JI2NDHZZIGMEZ375U.jpg)
